Heron Therapeutics
HRTX
HRTX
197 hedge funds and large institutions have $1.16B invested in Heron Therapeutics in 2021 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 74 increasing their positions, 45 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
4% more funds holding
Funds holding: 189 → 197 (+8)
28% less capital invested
Capital invested by funds: $1.61B → $1.16B (-$450M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
197
Holding in Top 10
2
Calls
$3.56M
Puts
$1.51M
Top Buyers
| 1 | +$23.6M | |
| 2 | +$19M | |
| 3 | +$14.5M | |
| 4 |
Goldman Sachs
New York
|
+$9.72M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$8.91M |
Top Sellers
| 1 | -$19.2M | |
| 2 | -$17.6M | |
| 3 | -$13.8M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$6.32M |
| 5 |
KHCM
Kettle Hill Capital Management
New York
|
-$5.78M |